Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

被引：0
|
作者：
Yoh Watanabe
Tomomaro Etoh
Eiji Koike
Yoshiaki Mizuno
Wei-Min Wang
Hiroshi Hoshiai
机构：
[1] Kinki University School of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2010年 / 15卷
关键词：
Recurrent ovarian cancer; Salvage therapy; Cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：468 / 471
页数：3
相关论文
共 50 条
  • [11] Salvage therapy with topotecan (topo) of heavily pretreated ovarian cancer patients (hpocp).
    Wcislo, GB
    Bodnar, L
    Miedzinska-Maciejewska, M
    Szczylik, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 484S - 484S
  • [12] Salvage therapy for recurrent epithelial ovarian cancer
    Baker, VV
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (04) : 977 - +
  • [13] Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma
    O'Malley, DM
    Azodi, M
    Makkenchery, A
    Tangir, J
    McAlpine, J
    Kelly, M
    Schwartz, P
    Rutherford, T
    GYNECOLOGIC ONCOLOGY, 2005, 98 (02) : 242 - 248
  • [14] Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
    Attianese, Daniela
    Massobrio, Roberta
    Giorgi, Margherita
    Villa, Michela
    Fuso, Luca
    Badellino, Enrico
    Bellero, Marco
    Ferrero, Annamaria
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (04) : 2183 - 2190
  • [15] Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated recurrent ovarian cancer.
    Sanchez-Munoz, A.
    Mendiola, C.
    Rodriguez, C. A.
    Perez-Ruiz, E.
    Jurado, J. M.
    Alonso-Carrion, L.
    Ghanem, I.
    Deelasco, G.
    Quero Blanco, C.
    Alba, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [16] RETROSPECTIVE STUDY OF COMBINATION CHEMOTHERAPY WITH ETOPOSIDE AND IFOSFAMIDE IN PATIENTS WITH HEAVILY PRETREATED RECURRENT OR PERSISTENT EPITHELIAL OVARIAN CANCER
    Shin, W.
    Kim, B. G.
    Bae, D. S.
    Paik, E. S.
    Choi, H.
    Choi, C. H.
    Lee, J. W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1666 - 1666
  • [17] Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
    Lee, Hee Jun
    Kim, Hee Seung
    Park, Noh Hyun
    Chung, Hyun Hoon
    Kim, Jae Weon
    Song, Yong Sang
    CANCER RESEARCH AND TREATMENT, 2013, 45 (01): : 40 - 47
  • [18] Salvage treatment with docetaxel for recurrent epithelial ovarian cancer
    Yoshimitsu Niwa
    Toru Nakanishi
    Kazuo Kuzuya
    Akihiro Nawa
    Shigehiko Mizutani
    International Journal of Clinical Oncology, 2003, 8 (6) : 343 - 347
  • [19] Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
    Kang, Heeseok
    Kim, Tae-Joong
    Choi, Chel Hun
    Lee, Jeong-Won
    Lee, Je-Ho
    Bae, Duk-Soo
    Kim, Byoung-Gie
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (05) : 945 - 950
  • [20] Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
    Patrizia Vici
    Domenico Sergi
    Laura Pizzuti
    Luciano Mariani
    Maria Grazia Arena
    Maddalena Barba
    Marcello Maugeri-Saccà
    Cristina Vincenzoni
    Enrico Vizza
    Giacomo Corrado
    Giancarlo Paoletti
    Federica Tomao
    Silverio Tomao
    Diana Giannarelli
    Luigi Di Lauro
    Journal of Experimental & Clinical Cancer Research, 32
12345